Contineum Therapeutics In...
12.89
0.12 (0.94%)
At close: Jan 15, 2025, 3:59 PM
12.96
0.54%
After-hours Jan 15, 2025, 04:00 PM EST

Contineum Therapeutics Inc. Class A Common Stock Forecast

Stock Price Forecast

The 4 analysts with 12-month price forecasts for CTNM stock have an median target of 30, with a low estimate of 25 and a high estimate of 32. The median target predicts an increase of 132.74% from the current stock price of 12.89.

Analyst Consensus: Buy
Target Low Average Median High
Price $25 $29.25 $30 $32
Change 93.95% 126.92% 132.74% 148.25%

AI Analyst Report

RBC Capital maintains an Outperform rating for Con... Unlock content with Pro Subscription

Updated Jan 09, 2025

Rating Apr 24Aug 24Oct 24Nov 24Jan 25
Strong Buy 00000
Buy 31111
Hold 00000
Sell 00000
Strong Sell 00000
Total 3 1 1 1 1

Financial Forecast this Year

Revenue This Year
50.00M
from 50.00M
Increased by 0.0%
Revenue Next Year
7.50M
from 50.00M
Increased by -85%
EPS This Year
-1.92
from 1.36
Increased by -41.2%
EPS Next Year
-1.81
from -1.92
Increased by 5.7%